Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiviral prophylaxis].

U B Graubner1

  • 1Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Klinikum der Universität München-Innenstadt, Abteilung Hämatologie und Onkologie, Germany.

Klinische Padiatrie
|September 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Supratentorial primitive neuroectodermal tumor: a single center experience and comparison with the literature].

Klinische Padiatrie·2005
Same author

[Vaccination].

Klinische Padiatrie·2001
Same author

Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT.

Bone marrow transplantation·2001
Same author

[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)].

Klinische Padiatrie·1999
Same author

Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.

Klinische Padiatrie·1998
Same author

[Congenital anemia].

Der Internist·1994

Antiviral prophylaxis for pediatric cancer patients undergoing stem cell transplants primarily targets herpes viruses like HSV, VZV, and CMV. Guidelines differ significantly for cytomegalovirus prevention between German and American recommendations.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Hematopoietic Stem Cell Transplantation

Background:

  • Antiviral prophylaxis in pediatric oncology and stem cell transplantation (SCT) is crucial for managing herpes simplex virus (HSV), varicella zoster virus (VZV), and cytomegalovirus (CMV).
  • These viruses pose significant risks of morbidity and mortality through primary infection or reactivation in immunocompromised pediatric patients.
  • Existing research and prophylaxis guidelines predominantly focus on adult populations, necessitating specific pediatric considerations.

Purpose of the Study:

  • To review and compare current antiviral prophylaxis strategies for herpes viruses in pediatric oncology and bone marrow transplantation (BMT)/SCT.
  • To identify discrepancies in recommendations, particularly concerning cytomegalovirus (CMV) prevention, between major international guidelines.
  • To highlight areas requiring further research and consensus-building for optimal pediatric patient care.

Related Experiment Videos

Main Methods:

  • Comparative analysis of published guidelines from German and American pediatric infectious disease and transplantation societies.
  • Review of existing literature on antiviral prophylaxis efficacy and safety in pediatric BMT/SCT recipients.
  • Identification of controversial aspects and areas lacking consensus in current recommendations.

Main Results:

  • Recommendations for herpes simplex virus (HSV) and varicella zoster virus (VZV) prophylaxis show substantial agreement between German and American guidelines.
  • Significant differences exist in recommendations for cytomegalovirus (CMV) disease prevention and recurrence management.
  • Current guidelines are largely based on adult data, with limited pediatric-specific evidence.

Conclusions:

  • While HSV and VZV prophylaxis strategies are largely harmonized, CMV prevention remains a complex and debated area in pediatric BMT/SCT.
  • Further collaborative research is needed among oncology and infectious disease working groups to establish consensus on CMV prophylaxis and VZV vaccination in pediatric SCT.
  • Standardized, evidence-based pediatric protocols are essential to mitigate herpes virus-related complications in this vulnerable population.